R01HL152728

Identifying Protein-Protein Network Interactions between COPD Susceptibility Genes - Project Summary

Genome-wide association studies (GWAS) of complex diseases like COPD have identified many genomic regions associated with the disease, but the molecular mechanisms by which these genetic loci influence disease pathogenesis are largely unknown.

The phenotypic effects of genetic alterations can result from disruptions of the coordinated interactions between proteins. However, the key genes within COPD GWAS loci have only been proven in a minority of those COPD GWAS regions, and network connections between the COPD GWAS gene products have rarely been identified.

In this project, we will utilize COPD susceptibility genes supported by both GWAS and murine emphysema models to develop cell type-specific and disease-specific protein-protein interaction network modules related to COPD. We hypothesize that building disease network modules based on experimentally validated protein-protein interactions between COPD GWAS genes will identify novel biological connections that influence COPD-related disease processes of cell death, cellular senescence, and/or inflammation.

We will perform affinity purification/mass spectrometry (AP-MS) assays of nine well-established COPD GWAS gene products. Interacting proteins that are part of network links between COPD GWAS genes based on the AP-MS assays will be further validated with co-immunoprecipitation assays.

We will utilize disease network module building approaches that combine the new AP-MS experiments with existing molecular interactome data to find biological linkages between COPD GWAS gene products. We will identify cell type-specific protein-protein interaction networks by removing non-expressed genes based on RNA-seq data in bronchial epithelial cells and alveolar macrophages, and disease-specific protein-protein interaction networks based on TOPMed RNA-seq data from lung tissue in the Lung Tissue Research Consortium.

For network paths linking COPD GWAS genes in the protein-protein interaction network, we will perturb disease network module components using CRISPR-Cas9 approaches. First, we will assess the effects of these perturbations on protein interactions of putative disease network paths. Second, we will assess the impact of these network node removal perturbations on cell-based COPD-related readouts, including cell death, cellular senescence, and inflammation. Positive phenotypic readouts in cell line experiments will be validated in primary human lung cells.

This project will combine state-of-the-art computational and laboratory approaches to identify the protein-protein interaction network relationships between COPD GWAS genes within multiple lung cell types and to validate those network relationships using cell-based readouts of relevant biological processes for COPD pathogenesis.

Brigham & Womens Hospital

NOT APPLICABLE

93.837 - Cardiovascular Diseases Research

National Heart Lung and Blood Institute (NHLBI) [HHS - NIH]

Boston, Massachusetts 021156110 United States

Single Zip Code

Research Project Grant (Parent R01 Clinical Trial Not Allowed) (PA-19-056)

Amendment Since initial award the total obligations have increased 291% from $812,488 to $3,177,138.